ACHV ACHIEVE LIFE SCIENCES, INC.
NEUTRAL
Impact: 2/10
8-K
8-K context-dependent: Items 5.02
Latest settled — T+1d
ACHV ▼ -2.19% at T+1d
NEUTRAL call ✗ call lost -2.19% · α vs SPY -1.49% · entry $5.03 → $4.92
Currently $5.14 · +2.19% from $5.03 entry
T+1d
-2.19%
call -2.19% · α -1.49%
$4.92
settled 2d ago
T+5d
—
call — · α —
—
in 4d
T+20d
—
call — · α —
—
in 26d
T+60d
—
call — · α —
—
in 3mo
Price Chart
Loading chart...
Executive Summary
Achieve Life Sciences appointed Jeff Farrow and Dr. Reid Waldman as directors effective May 29, 2026. Both receive standard non-employee director compensation: a pro-rated $40,000 annual retainer and options for 47,250 shares vesting over three years. This is a routine board expansion with no unusual terms or departures.
Actionable Insight
Routine board appointments with no material financial or strategic impact. No immediate trading action warranted.
Key Facts
- Jeff Farrow and Reid Waldman, M.D. appointed to the board on May 29, 2026.
- Farrow appointed to Nominating/Governance Committee and as Audit Committee Chair.
- Waldman appointed to Commercial Committee and as Compensation Committee Chair.
- Each new director receives pro-rated $40,000 annual retainer and 47,250 stock options vesting monthly over three years.
- Standard indemnification agreements entered into with each director.
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
93% bullish (14 analysts)
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-252624 |
| Document: 0001193125-26-252624-index-headers.html | 0001193125-26-252624 |
| Document: 0001193125-26-252624-index.html | 0001193125-26-252624 |
| Document: 0001193125-26-252624.txt | 0001193125-26-252624 |
9 reports for ACHV
100%
Hit rate
best @ T+20▲ +23.91%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
3d ago
|
8-K
| $5.03 $4.92 | ▼ −2.19% | ▼ −1.49% | $5.14 (+2.19%) |
|
May 22, 2026
14d ago
|
EFFECT
| — | awaiting T+1 | — | — |
|
May 19, 2026
17d ago
|
Press Release
| $4.45 $4.57 | ▲ +2.70% | ▲ +1.66% | $5.14 (+15.51%) |
|
May 12, 2026
24d ago
|
8-K
| $5.99 $5.96 | ▼ −0.50% | ▼ −1.08% | $5.14 (−14.19%) |
|
May 12, 2026
24d ago
|
Press Release
| $5.99 $5.96 | ▼ −0.50% | ▼ −1.08% | $5.14 (−14.19%) |
|
Apr 16, 2026
7w ago
|
8-K
| $5.10 $4.25 | ▲ +16.67% | ▲ +16.48% | $5.14 (−0.78%) |
|
Apr 16, 2026
7w ago
|
Press Release
| $4.81 $5.10 | ▲ +6.03% | ▲ +4.81% | $5.14 (+6.86%) |
|
Apr 15, 2026
7w ago
|
Press Release
| $3.55 $4.81 | ▲ +35.49% | ▲ +35.24% | $5.14 (+44.79%) |
|
Mar 24, 2026
10w ago
|
Press Release
| $2.90 $2.82 | ▼ −2.76% | ▼ −3.33% | $5.14 (+77.24%) |
Showing 9 of 9
US Market Status
Market Open — Closes in 5m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access